Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / AMRX - Amneal Pharmaceuticals Non-GAAP EPS of $0.14 misses by $0.04 revenue of $545.56M misses by $16.61M

AMRX - Amneal Pharmaceuticals Non-GAAP EPS of $0.14 misses by $0.04 revenue of $545.56M misses by $16.61M

Amneal Pharmaceuticals Inc. Class A
  • Amneal Pharmaceuticals press release ( NYSE: AMRX ): Q3 Non-GAAP EPS of $0.14 misses by $0.04 .
  • Revenue of $545.56M (+3.2% Y/Y) misses by $16.61M .
  • Reaffirms FY2022 Guidance : Reaffirms Net revenue to $2.15B-$2.25B vs. consensus of $2.20B; Adj EPS from prior $0.80-$0.85 to $0.65-$0.70 vs consensus of $0.68; Adj. EBITDA from prior of $540M-$560M to $500M-$520M.

For further details see:

Amneal Pharmaceuticals Non-GAAP EPS of $0.14 misses by $0.04, revenue of $545.56M misses by $16.61M
Stock Information
Company Name: Amneal Pharmaceuticals Inc. Class A
Stock Symbol: AMRX
Market: NASDAQ
Website: amneal.com
Menu
AMRX AMRX Quote AMRX Short AMRX News AMRX Articles AMRX Message Board
Get AMRX Alerts

News, Short Squeeze, Breakout and More Instantly...